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THE presence in tumour tissue of some substance, capable of depressing the
liver catalase activity in mice has been established recently in a number of
laboratories (Nakahara and Fukuoka, 1949, 1950; Adams, 1950a, 1951; Green-
field and Meister, 1951). It therefore seems reasonable to suppose that the action
of a growing tumour on liver catalase is due to the release of this substance into
the circulation. So far, however, little is known of the mechanism by which the
catalase-depressing substance exerts its effect, or of any significance it may have
so far as the tumour itselfis concerned. In a preliminary report on the changes in
mouse liver catalase level which occur after castration and adrenalectomy, it was
tentatively suggested that tumour tissue might be acting by interference with
hormonal stimulation of the liver (Adams, 1950b). Before this suggestion could
be investigated, it was found necessary to examine in some detail the hormonal
factors influencing liver catalase activity in the normal mouse. The results
obtained may be briefly summarised as follows. There is a sex difference in
normal catalase activity, males having the higher level. Castration of males
reduces the catalase activity to slightly below the normal female level within
48 hours. Administration oftestosterone to castrated males restores their normal
catalase activity; when administered to normal females it elevates their catalase
level to that ofthe male. Adrenalectomy in both sexes produces afall in activity,
restored to normal by cortisone (Adams, 1952). Adrenalectomy in rats also
results in a depression of liver catalase activity, according to Begg and Reynolds
(1950).
The present paper describes some preliminary results which support the hypo-
thesis that in an animal treated with tumour homogenates, the adrenal and
testicular factors normally influencing liver catalase activity are prevented from
operating. This failure appears to be due to the inability ofthe liver to respond
to the hormonal stimuli.
MATERLALS AND METHODS.
Animals.-Young adult mice of a stock albino strain (weighing 25 to 30 g.)
were used. The diet of the animals consisted of rat cubes (Rowett Institute
formula), and water ad libitum.
Tumour.-Sarcoma 37 (originally obtained from the Chester Beatty Research
Institute) has been used throughout. The tumour was administered by the
injection of a coarse homogenate prepared with a TenBroeck grinder.4D. HI. ADAMS
Estimation ofliver catalase;-Samples ofwhole liver homogenates were allowed
to react with M/40 hydrogen peroxide (A.R. quality) in M/50 phosphate buffer
(pH 6.8) at 00 C., the reaction being stopped after 4 minutes by the addition of
sulphuric acid. The hydrogen peroxide remaining was estimated by titration
with standard sodium thiosulphate solution, afterthe addition ofexcess potassium
iodide. Corresponding determinations oftotal nitrogen were made (by Kjeldahl),
catalase levels being expressed in arbitrary units/mg. N. For details see Adams
(1950a).
Operative procedure.-Castration and adrenalectomy were carried out under
ether-chloroform anaesthesia, as previously described (Adams, 1952). In an
additional attempt to combat shock following adrenalectomy, glucose (0.5 per
cent w/v) was added to the drinking water (already containing 0 5 per cent
sodium chloride) for 48 hours following operation.
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FIG. 1.-Effect of the intraperitoneal injection of varying doses of Sarcoma 37 homogenate
on the liver catalase activity ofthe groups of mice detailed. Catalase levels 48 hours after
tumour injection. (a) normal males, (b) castrated males receiving testosterone (60 pg./day),
(c) castrated males, (d) normal females, (e) normal females receiving testosterone (60,ug./
day). Results are given as arithmetic means ± standard error of means. The number
of animals in the groups are given by the small figures at the bead of the standard error
limits.
Hormones.-Testosterone (commercially supplied for implantation). Corti-
sone (17-hydroxy 11-dehydro corticosterone), kindly provided by Professor
C. Wilson. These were injected subcutaneously in 50 per cent alcohol-water
solution and in daily doses.
RESULTS.
During the course of the previous investigations (Adams, 1950a, 1951) it
was observed that, coupled with a sex difference in normal liver catalase activity
(males > females), there is a bigger initial fall in male catalase level after tumour
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injection. This was true of all four tumours which were injected into both sexes.
To investigate this effect further, curves of Sarcoma 37 dosage against catalase
level 48 hours after intraperitoneal injection were plotted for the following
5 groups of mice-normal males, castrated males, castrated males receiving
testosterone (normal catalase level restored), normal females, females receiving
testosterone (catalase elevated to approximately the normal male level). The
groups treated with testosterone were injected subcutaneously with 60 ,sg./day
during the experiment, the tumour homogenate being given on the sixth day.
The results appear in Fig. 1, and show that normal males and castrated males
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FIG. 2.-Effect of the repeated daily injection of 100 mg. 837 (as homogenate) on the liver
catalase activity of (a) normal males, (b) castrated males, and (c) castrated and adrenalec-
tomised males. The control groups (no S37) appear on the left-hand sides of the graphs
(abscissa points 0, 0, 0). In this and the subsequent figures the points represent individual
mice and the crosses the arithmetic mean values of the groups.
receiving testosterone behaved in a very similar way; there was a progressive
fall in catalase activity with increasing tumour dosage, which was approximately
equal in the 2 groups. The effect of the tumour on castrated males was not
significant, contrasting with the steep fall in the first 2 groups. Normal females
showed a small depression in catalase activity after the injection of tumour, the
change in level being less than with normal males, as previously observed. The
catalase depression in the females receiving testosterone, however, was closely
similar to that shown by normal males and castrated males receiving testosterone.
Hitherto in this work tumour has been administered in single doses, and theD. H. ADAMS
catalase activity determined after an interval or intervals. It seemed ofinterest
to determine the maximum depression of liver catalase which can be produced
by tumour homogenates in the absence of tumour growth, and this was done by
observing the effect of the repeated injection of high doses. Up to about 5 daily
injections may begiven before visiblesigns oftumourgrowth appear. Sarcoma 37
in 100 mg. doses was injected daily into normal male mice by the intraperitoneal
route, and the catalase level determined daily. Fig. 2 shows the results of this
experiment. The catalase activity fellfrom the control level ofsome 140 arbitrary
units/mg. N. to 65 arbitrary units/mg. N. within 48 hours, and then remained
constant. It seemed significant that this is approximately the level of activity
reached after castration and adrenalectomy. Fig. 2 also shows the effect of
injecting 100 mg./day of S37 into castrated males. Although the initial level
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Fie. 3.-Effect of the repeated daily injection of l0 mg. S37 (as homogenate) on the liver
catalasa activity of (a) normal females, and (b) adrenalectomised females. The control
groups (no S37) appear on the left-hand sides ofthe graphs (abscissa points 0, 0). In the
adronalectomised females the second dose was reduced to 70 mg.
of catalase activity is much lower, the same ultimate point is reached, i.e., some
60 to 65 arbitrary units/mg. N. From the third graph in Fig. 2 it may be seen
that this is, in fact, the level reached after castration and adrenalectomy, and
that the injection of tumour homogenate into castrated and adrenalectomised
animals had little or no effect on catalase level. This was despite the fact that
the mortality rate amongst castrated and adrenalectomised mice injected with
tumour homogenate was extremely high, the survivors making up only 2 full
groups. These results suggest most strongly that the extent to which catalase
activity can be depressed by tumour homogenate is sharply limited, and it is that
part of the total activity governed by the testicular-adrenal hormones which is
affected.
Normal females treated with 100 mg./day doses of tumour are similarly
affected (Fig. 3). The catalase level falls, but only dow-n to about 60 arbitrary
units/mg. N. This is only slightly below the level reached after adrenalectomy..
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The similarity between the response of normal females and castrated males is
well illustrated in Fig. 2 and 3.
Fig. 3 also shows that the effect of injected tumour homogenate on adrenalec-
tomised females is small. However, the toxicity of the tumour tissue in these
mice was even higher than in the males, 20/35 mice dying within 24 hours after
the first injection of 100 mg. In an attempt to conserve the survivors, the second
dose was reduced to 70 mg., and this was successful, there being no further deaths.
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FIG. 4.-Effect of the repeated daily injection of 100 mg. S37 (as homogenste) on the liver
catalase activity of (a) adrenalectomised females, (b) castrated and adrenalectomised
males; both groups were treated with 50 ,g. of cortisone daily beginning 5 days before
tumour injection. The control groups (no S37) appear at abscissa points 0, 0. The
catalase levels of normal and operated animals are shown for comparison at the extreme
left of each graph. (A, normal females, B, adrenalectomised females; c, normal males;
D, castrated and adrenalectomised males).
In order to obtain some direct evidence bearing upontheilihibition ofcortisone
stimulation by tumour injection a group of female mice was adrenalectomised,
and the normal catalase level restored by the daily injection of 50 ,tg. of cortisone
for 5 days. Sarcoma 37 was then injected daily in 100 mg. doses (the cortisone
treatment being continued). As Fig. 4 shows, there was an immediate sharp
fall in catalase activity to around 65 arbitrary units, the level remaining constant
at this figure. There was some mortality following the injection of tumour, but
the rate (6/35 in 24 hours; no subsequent deaths) was considerably lower than
amongst the adrenalectomised mice not treated with cortisone.D. H. ADAMS
Although it was shown (Adams, 1952) that cortisone and testosterone exert
independent effects on catalase, evidence was obtained favouring the supposition
that there is some adrenal mediation in testosterone secretion. In view of this
possible interaction between the testicular and adrenal systems, it was thought
better to use castrated and adrenalectomised animals treated with cortisone for
the examination of the tumour-cortisone relationship in males. The results
appear in Fig. 4. As previously found (Adams, 1952), cortisone treatment of
these animals did not restore the catalase activity to normal, although an appre-
ciable rise was observed. As in the adrenalectomised, cortisone-treated females
a fall in catalase activity resulted from the daily injection of tumour homogenate.
Although the fall in activity after tumour injection occurred more slowly than in
the adrenalectomised female mice treated with cortisone, the extent of the fall
was again approximately equal to the rise induced by the cortisone treatment.
In this group ofmice there were no deaths for 48 hours following tumour injection.
DISCUSSION.
The results confirm the previous observation (Adams, 1950a, 1951) that the
immediate depression in liver catalase activity following the injection of tumour
homogenates is greater in males than in females. Castrated males behave
similarly to normal females after tumour injection. Castrated males and normal
females react as normal males after their catalase activity has been raised by
testosterone injection. The continued injection of tumour tissue into normal
males lowers their catalase activity approximately to the point reached after
castration and adrenalectomy, i.e., 60 to 65 arbitrary units/mg. N. Castrated
animals treated in the same way reach the same ultimate catalase level despite
their lower initial activity. Adrenalectomy of castrated animals reduces the
liver catalase activity to around 65 units as stated above, and the subsequent
injection of tumour produces little or no change. In adrenalectomised females
the final level and behaviour towards tumour injection is similar to that of
castrated and adrenalectomised males. Restoration of the adrenal-controlled
component of the catalase activity by cortisone injection restores the sensitivity
to tumour. In each case the removal, or absence, of the gland results in a loss
of sensitivity to the catalase-depressing effect of tumour injection, which is
quantitatively restored by the injection of the appropriate hormone. It is
possible, however, that there is some other small component of the catalase
activity which is tumour-sensitive some of the levels in tumour-treated animals
were slightly lower than those after adrenalectomy in females or castration and
adrenalectomy in males. Possibly there is some direct pituitary contribution.
Nevertheless, it seems that by far the greater part of the liver catalase activity
which is sensitive to tumour homogenates is normally under adrenal and testicular
control. The effect of a large growing tumour is a little greater than that of
tumour homogenates, since average catalase levels of about 45 arbitrary units
have previously been recorded in S37 bearing mice (Adams, 1950a). The gap
may well be due to non-specific changes in nutritional status associated with
tumour growth.
The important feature of the present results lies in the blocking effect of the
catalase-depressing substance on hormonal stimulation of the liver, particularly
since an essential substance such as cortisone is involved. How many of the
functions of cortisone in the liver suffer interference is not known but it would
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seem unlikely that the effect is confined to liver catalase. The concentrations
of other liver enzymes and components are known to be altered in the tumour-
bearing animal (Greenstein, 1947). It seems reasonable to suppose that at least
some of these changes may be effected in the same way as the depression of liver
catalase-i.e., through an interference with svstemic influences. However, the
main interest ofthese liver changes is in the possibility that they may throw light
on processes occurring within tumours, particularly on those responsible for their
" autonomous " nature. Greenstein (1947) has pointed out that the changes
which occur in the liver of a tumour-bearing animal are in the direction which the
liver would take ifit were transformed into a hepatoma. The isolation ofthe liver
from systemic controlling influences may be interpreted as a step towards
autonomy. Possibly, therefore, the function ofthe catalase-depressing substance
within the tumour is to protect it against interference from systemic influences,
and this substance may be responsible for the autonomous nature of tumour
growth.
It is not yet known whether cortisone and testosterone are capable of exerting
any protection against the catalase-depressing substance of tumours. According
to Begg (1951) testosterone does not restore the catalase level in rats bearing large
tumours, but non-specific nutritive effects may interfere under these conditions.
Fukuoka and Nakahara (1951) have recently reported the interesting obser-
vation that liver catalase is restored to normal in tumour-bearing mice by feeding
or injecting ferric chloride. These authors suggest that tumours may interfere
with the incorporation of iron into liver catalase, and that other iron-containing
enzymes may be found to be affected. It would be interesting to investigate the
relationship between iron and the hormones in the maintenance of liver catalase
activity.
SUMMARY.
The liver catalase activity of normal male mice, which is higher than that of
female or castrated male mice, is depressed to a greater extent than that of the
latter by injection of homogenised S37 tissue.
Normal females and castrated males treated with testosterone (which raises
their liver catalase level) react to tumour injection like normal males.
There is a limit to the capacity of injected tumour tissue to depress liver
catalase activity, the final enzyme level being approximately that reached after
castration and adrenalectomy in males, or adrenalectomy in females.
Injection oftumour into adrenalectomised females, or castrated and adrenalec-
tomised males, results in little or no further depression in catalase activity.
Injection of cortisone into adrenalectomised females, or castrated and
adrenalectomised males, raises the liver catalase level. Injection of tumour into
animals treated in this way depresses the level again, and the extent of the fall is
approximately equal to the rise produced by cortisone.
The substance produced by tumours which depresses liver catalase activity
appears to act by protecting this liver enzyme from hormonal influences. It is
suggested that other changes in the liver of tumour-bearing animals may be
produced in a similar way, and the hypothesis is advanced that the substance
has a protective function within the tumour itself.
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